Data Foundry

Drug recalls 2021

Cistus Canadensis 6X — Class II drug recall D-0865-2021

Terminated recall by Washington Homeopathic Products, Inc., reported 2021-10-06, distributed nationwide. Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Recall numberD-0865-2021
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmWashington Homeopathic Products, Inc., Berkeley Springs, WV, United States
Recall initiated2021-08-20
Classified2021-09-29
Reported by FDA2021-10-06
Terminated2022-06-21
DistributedNationwide (US)
Quantity17 bottles
UPC / GTIN / UDI-DI00740640281710, 00740640281734, 00740640281758, 00740640281772
Lot numbers28638
Expiration dates2026-08-17

Product

Cistus Canadensis 6X, 10X, 15X, 30X, Coldness* Sucrose/Lactose Pills, 6X Packaged as a) 1 OZ, UPC 7 40640 28177 2, b) 4 dr, UPC 7 40640 28173 4; 10X Packaged as c) 4 dr; 15X Packaged as d) 1 OZ; 30X Packaged as e) 2 Dram, UPC 7 40640 28171 0, f) 4 dr, UPC 7 40640 28175 8; WHP Homeopathic Medicine, Washington Homeopathic Products 260 JR Hawvermale Way, Berkeley Springs WV 25411

Reason for recall

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0865-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.